Windlass Biotech Windlas Biotech Ltd.NSE:WINDLASMicrocap_Investor💊 STOCK TO WATCH 💊 ₹1,060–1,070 → ₹1,462 → ₹2,888 👀 A pharma/CDMO name appearing on my Weekly R4 Momentum Breakout Scanner. Windlas Biotech Ltd. 📌 Buy Zone: ₹1,060–1,070 📌 Breakout Zone: ₹1,056 🛑 Stop Loss: ₹751 🎯 Target 1: ₹1,462 🎯 Target 2: ₹2,888 Why Windlas Biotech? 🧬 CDMO + formulations play: Windlas operates across generic formulations CDMO, domestic trade generics/institutional sales and exports, giving it multiple revenue engines. 🌍 Growing export opportunity: FY25 export revenue grew 19% YoY to ₹32.6 Cr, with 69 products exported to global partners. 🏭 Regulated manufacturing base: Its facilities include WHO-GMP-approved plants, with Plant 4 approved for markets including Europe, Canada and South Africa; Plant 5 adds injectable manufacturing capability. 💊 Complex-generic opportunity: The company is expanding product-development and manufacturing capabilities in complex generics and specialised dosage forms. 📈 Strong operating track record: Windlas reported Q1 FY26 revenue of ₹210 Cr, EBITDA ₹27 Cr and PAT ₹18 Cr, with YoY growth of 20%, 27% and 31%, respectively. Why It Caught My Attention ✅ CDMO + branded formulations + exports ✅ Complex-generic opportunity ✅ WHO-GMP manufacturing infrastructure ✅ Injectable manufacturing capability ✅ Growing international presence ✅ Strong recent operating momentum 🔥 Weekly R4 Momentum Breakout ⚠️ HIGH RISK – HIGH REWARD SETUP. The technical levels above are your scanner-defined levels. The ₹751 stop-loss should be treated as the risk-control point, while execution, margins and export growth need continued monitoring. Risk Defined. Reward Visible. 📢 Disclaimer: This content is for educational purposes only and not investment advice. Please do your own due diligence before making any investment decisions. © 20K Microcap Investing | R4 Momentum Desk #WindlasBiotech #WINDLASS #PharmaStocks #CDMO #PharmaceuticalStocks #ComplexGenerics #SmallCapStocks #HealthcareStocks #StockMarketIndia #IndianStocks #StocksToWatch #R4Breakout #MomentumInvesting #20KMicrocap